Nutrient overload occurs worldwide as a consequence of the modern diet pattern and the physical inactivity that sometimes accompanies it. Cells initiate multiple protective mechanisms to adapt to elevated intracellular metabolites and restore metabolic homeostasis, but irreversible injury to the cells can occur in the event of prolonged nutrient overload. Many studies have advanced the understanding of the different detrimental effects of nutrient overload; however, few reports have made connections and given the full picture of the impact of nutrient overload on cellular metabolism. In this review, detailed changes in metabolic and energy homeostasis caused by chronic nutrient overload, as well as their associations with the development of metabolic disorders, are discussed. Overnutrition-induced changes in key organelles and sensors rewire cellular bioenergetic pathways and facilitate the shift of the metabolic state toward biosynthesis, thereby leading to the onset of various metabolic disorders, which are essentially the downstream manifestations of a misbalanced metabolic equilibrium. Based on these mechanisms, potential therapeutic targets for metabolic disorders and new research directions are proposed.
INTRODUCTION
Chronic nutrient overload is a modern occurrence caused by changes in dietary patterns and lifestyle, with obesity being the primary manifestation. 1 In the past decade alone, the prevalence of obesity and other related medical disorders, such as type 2 diabetes, 2 cardiovascular diseases and atherosclerosis, 3 and even cancer, 4 has increased dramatically in the United States and throughout much of the world. 4 Although the cited conditions can present in isolation, in tandem, or concurrently according to the responsiveness of an individual, 5, 6 they share similar changes in metabolic and energy homeostasis. Additionally, changes in cellular homeostasis can be effected by failing to maintain nutrient balance. 7 Multiple protective responses and pathways are initiated to help cells adapt to elevated nutrients, and thereby metabolites. These include increased production and signaling of reactive oxygen species (ROS) by the mitochondria, unfolded protein responses (UPRs) by the endoplasmic reticulum (ER), and the activation of the mechanistic target of rapamycin (mTOR). 8 However, chronic and persistent nutrient overload causes severe and irreversible damages to the mitochondria 9 and ER, 10 the downregulation of adenosine monophosphate (AMP)-activated protein kinase (AMPK), 11 and modifications to metabolic-sensitive proteins through the deactivation of sirtuins, 12 which may be the first step in the development of a metabolic disorder. The purpose of this review is to study and integrate recent developments in metabolic stress caused by overnutrition drawn from animal studies as well as in vitro studies with cultured cells. In this review, metabolic responses to nutrient overload facilitated by excessive fatty acids, carbohydrates, or amino acids are discussed with an emphasis on the organelles and nutrient sensors that play key roles in maintaining energy homeostasis at the cellular level.
NUTRIENT OVERLOAD-INDUCED ORGANELLE STRESS
The mitochondria and ER can be classified as nutrient sensors due to their respective functions in energy generation and biosynthesis. Aerobic respiration, facilitated by the tricarboxylic acid (TCA) cycle and electron transport chain (ETC), occurs in the mitochondria and is a main generator of adenosine triphosphate (ATP). 13 The ER participates in both protein synthesis and lipid metabolism because various transcriptional factors, regulatory proteins, and enzymes that regulate lipogenesis and oxidation reside on its membrane. 14 As the power houses and building factories of the cell, the mitochondria and ER can experience stress and even long-term damage due to fluctuations in nutrient and substrate availability.
Mitochondrial stress
Excess nutrient intake causes mitochondrial stress by saturating the TCA cycle and ETC, which in turn affects the capability of mitochondria to recycle the electroncarrying coenzymes NADH, and FADH 2 back to NAD þ and FAD þ . For example, Kim et al 15 reported significantly (P < 0.029) decreased NAD þ /NADH ratios in the liver of a mice model fed a high-fat diet. These results were supported by the work of Boulang e et al, 16 who determined that turnover of NAD þ /NADH was accelerated in response to nutrient overload, as evidenced by a constant increase of the end product of NAD pathways in the urine of mice fed a high-fat diet. Because nutrient overload reduces the ability of the mitochondria to regenerate NAD þ , the stressed cell is forced to upregulate NAD þ salvage, as was shown by Penke et al. 17 In the study by Penke et al, nicotinamide phosphoribosyl transferase, the rate-limiting enzyme for NAD þ salvage, was significantly enhanced at both the translational (P < 0.01) and posttranslational (P < 0.001) levels in the liver of mice fed a high-fat diet. 17 Conversely, Cant o et al 18 demonstrated that the mitochondria may be protected from abnormalities caused by chronic nutrient consumption by generation of higher levels of NAD þ . Specifically, oxidative phosphorylation was enhanced in the skeletal muscle of mice fed a high-fat diet supplemented with nicotinamide ribose, a NAD þ precursor. 18 Healthy mitochondria generate ATP via low proton motive forces with a concomitant larger electrochemical gradient across the inner membrane. Nutrient overload can affect this mechanism by altering the mitochondrial electrical potential and proton gradient and thus the rate of ATP production, as seen in the liver of rats subjected to a high-fat diet. 19 Proton and electron leakage also increases in the cell as an adaptation response that involves the delivery of electrons from NADH and FADH 2 to ETC complexes I and III (defined as mitochondria bioenergetic efficiency). 9 Excess fuel within the mitochondria without an increased demand for energy stimulates higher oxidant production, 20 most likely originating from ETC complexes I, II, and/or III. Early studies, which primarily used isolated mitochondria, identified ETC complexes I and III as the major producers of oxidative species under physiological conditions. 21 Nishikawa et al 22 showed that ETC complex II is also a key ROS producer because its inhibition prevented higher oxidant levels in a hyperglycemia cell model. Ruiz-Ram ırez et al 23 further showed that mitochondria isolated from the liver of mice fed a chronic high-sucrose diet presented with increased hydrogen peroxide (H 2 O 2 ) levels and proton leakage. By adding exogenous oleic or linoleic acid to the diet, the rate of H 2 O 2 generation was exacerbated. 23 Similarly, Vial et al 24 reported that mitochondrial alterations, including quinone pool downsizing and substantially higher H 2 O 2 levels, occurred in freshly isolated hepatocytes exposed to high fat. In addition, the lifespan of superoxide-generating electron transport intermediates, such as ubisemiquinone, were prolonged under nutrient surplus conditions, resulting in higher superoxide levels. 22 Interestingly, diverse types of fat differ in their effects on mitochondrial function. A diet high in saturated fats reduced mitochondria biogenesis markers (peroxisome proliferator-activated receptor [PPAR] c coactivator 1-alpha [PGC-1a] and mtDNA), mitochondrial fatty-acid oxidation enzyme (acetyl CoA carboxylase), and TCA cycle and ETC enzymes (a panel of 44 enzymes and proteins), imposing severe damages to mitochondrial function in the epididymal white adipose tissue of mice, which was prevented by an unsaturatedfat diet (fish oil), 25 which was composed of a high level of n-3 fatty acids. This result is in accordance with those from studies conducted by Lionetti et al, 26 which found that a diet high in saturated fats increased proton leakage and ROS production in hepatic mitochondria compared with a high fish oil diet rich in unsaturated fatty acids, suggesting reduced mitochondrial efficiency.
Low levels of mitochondrial oxidants can be regulated by antioxidants and be incorporated into immune pathways. 27 Although originally considered a byproduct of oxidative phosphorylation (OXPHOS), ROS contribute to various signaling pathways, as reviewed by Collins et al 28 However, excess ROS are cytotoxic and affect multiple mitochondrial functions, such as slowing the rate of fatty-acid oxidation and OXPHOS. 29 Reactive oxygen species also act upon the building blocks of a cell by damaging their integrity, causing mitochondria fragmentation, 30 and/or damaging membranes of organelle compartments via lipid oxidation. 31 Other macromolecules, such as protein and DNA, are affected by ROS, leading to molecular configuration changes, enzymatic function impairment, or even premature cell death. 31 In response to such injuries, the cell prevents additional oxidative damage by initiating survival mechanisms, such as elevated inflammatory signals. For instance, Bekkering et al 31 showed increased proinflammatory cytokine production and foam cell formation when human monocytes were exposed to oxidized low-density lipoprotein. If the oxidative stress is caused by prolonged nutrient overload, a higher amount of oxidable substrate is available in circulation and within the cell, thereby a more detrimental impact on cellular metabolism is expected.
PGC-1a functions as a central regulator of cellular energy homeostasis, mostly because it directly participates in mitochondrial biogenesis and oxidative metabolism and coordinates many transcription factors that regulate mitochondrial functions in response to external stimuli. 32 In tissue with high oxidative capacity, such as liver, PGC-1a is a potent positive regulator of TCA cycle flux, fatty-acid oxidation, and hepatic gluconeogenesis. 33 Its knockout 34 or downregulation under nutrient overload conditions 35 reduced flux through the TCA cycle and mitochondrial fatty-acid b-oxidation, lowered the expression of TCA cycle and OXPHOS genes, and lowered the oxygen consumption of mitochondria, which reflects and coincides with substantial mitochondrial dysfunction and can be indirectly associated with oxidative stress and insulin resistance 36, 37 ( Figure 1) . 25, [38] [39] [40] Besides this indirect connection to redox balance, PGC-1a also directly impacts on cellular oxidative status by regulating the mitochondrial antioxidant defense system 41 ; as a strong regulator of ROS metabolism, PGC-1a is required for the induction of many ROS-detoxifying enzymes, including glutathione peroxidase 1 and superoxide dismutase 2. 42 Apart from its regulation of mitochondria, PGC-1a also participates in the maintenance of energy homeostasis via its own posttranslational modification. Adenosine monophosphate-activated protein kinase and silent mating type information regulator 2 homolog 1 (SIRT1) are positive regulators of PGC-1a through phosphorylation 43 and deacetylation, 44 respectively. In situations of energy depletion, AMPK activates SIRT1 by increasing the NAD þ level, which leads to the deacetylation and activation of PGC-1a. 43 Upon consumption of calorie-rich diets or in cases of energy abundance, AMPK is inhibited by high intracellular ATP levels, and histone acetyltransferase GCN5, which plays the opposite role of SIRT1, acetylates, hence deactivates, PGC-1a. 45 mTOR is also an upstream activator Figure 1 Illustration of mitochondrial dysfunction. In this review, mitochondrial dysfunction refers to the changes in mitochondria that lead to a loss of oxidative efficiency. These changes include but are not limited to a reduction in mitochondrial biogenesis and content, 25 impaired tricarboxylic acid (TCA) cycle and electron transport chain (ETC), 25 and the decoupling of the TCA cycle and the ETC. 38 Impaired ETC causes increased electron leakage and higher reactive oxygen species production, followed by oxidative stress and cellular damage, as well as possible activation of inflammatory response. De novo lipogenesis is elevated to accommodate unprocessed substrate, which inhibits multiple sites on the insulin signaling pathway. 39, 40 Abbreviations: Akt, protein kinase B; ETC, electron transport chain; IRS, insulin receptor substrate; PGC-1a, peroxisome proliferator-activated receptor c coactivator 1-alpha; ROS, reactive oxygen species; TCA, tricarboxylic acid.
of PGC-1a through the mTOR-yin yang 1 (YY1)-PGC1a pathway, 46, 47 which plays a key role in the regulation of glucose homeostasis and insulin signaling in skeletal muscle. 48 Perturbations in this metabolic network controlling PGC-1a activity may well lead to the reprogramming of cellular energetic pathways and, ultimately, systemic metabolic complications.
Endoplasmic reticulum stress
The ER links nutrient sensing to cellular signaling through the UPRs. 49 Studies have shown that changes in cellular metabolic homeostasis reduce the folding capacity of the ER and result in the accumulation of unfolded proteins, which triggers ER stress. Koumenis et al 50 reported that ER present in human and rodent cells rapidly stressed when exposed to moderate hypoxic conditions, as evidenced by the hyperphosphorylation of eukaryotic initiation factor 2a (eIF2a) and protein kinase-like ER kinase (PERK), thus attenuating protein synthesis. Yet, protein synthesis can be activated when cells are reoxygenated, indicating that oxygenation greatly affects ER function. 50 In order to adapt to stress caused by homeostasis turbulence, the ER initiates UPRs to manage excess nutrients and unfolded proteins so as to adjust to environmental changes. 49 The UPRs relieve ER stress by reducing protein translation, assisting in protein folding, and degrading misfolded proteins. 10 Still, failure to adapt may lead to pathological conditions, such as initiation of multiple inflammatory pathways (Figure 2 ), 14, 49, 51 as reviewed by Hotamisligil, 52 and even activation of apoptosis cascades. 14 The ER is deeply involved in lipid homeostasis because many enzymes and regulatory proteins, such as sterol regulatory element binding protein (SREBP) family, 14 which plays a critical part in de novo lipogenesis, reside in this organelle. 53 Moreover, growing evidence has shed light on the involvement of ER stress in hepatic lipid accumulation. [54] [55] [56] Endoplasmic reticulum stress is known to reduce the secretion of very-lowdensity lipoprotein from the liver by negatively affecting its assembly from triglyceride, cholesterol, and the ER client protein apolipoprotein B100. 57 Meanwhile, ER stress inhibits fatty-acid oxidation in the liver. DeZwaan-McCabe et al 58 showed that fatty-acid oxidation and its activator PPARa were both significantly (P < 0.01) suppressed in ATF6a À/À mice. Sustaining fattyacid oxidation by activating PPARa ameliorated hepatic lipid accumulation but was not able to suppress ER stress completely. Research conducted by Chan et al 59 showed that PPARa activator completely corrected hepatic lipid accumulation by increasing fatty-acid oxidation in mice fed a high-fructose diet but was not able to reduce ER stress despite partial activation of UPRs. Interestingly, the fatty-acid composition of the lipid consumed by animal or cell models matters to ER function and stress because different fatty-acid profiles led to quite diverse results. Zhao et al 60 fed rats a high-fat diet enriched with either lard oil or soybean oil with the objective of producing similar weight gains. Although no statistical difference in weight gain was found between the 2 diets, the diet enriched with lard oil resulted in significantly (P < 0.05) higher inflammatory responses, such as elevated expressions of hepatic tolllike receptor (TLR) 4, TLR2, and tumor necrosis factor a mRNA. Additionally, stress in the ER in response to the lard diet was evidenced by the increased expression of UPR markers PERK, phospho-eIF2a, and CHOP. 60 Although soybean oil did not exhibit an effect as deleterious as lard oil in this study, it caused considerable ER and mitochondrial damage in primary rabbit hepatocytes and ultimately resulted in lipid accumulation and ER stress, 61 evidenced by drastic ER expansion and mitochondrial swelling with many lipid droplets present. Fish oil rich in n-3 polyunsaturated fatty acids, by contrast, did not impose such damages on the ER. 61 In fact, Yang et al 62 demonstrated that docosahexaenoic acid inhibited palmitic acid-triggered ER stress in differentiated 3T3-L1 adipocytes, possibly through increased phosphorylation of AMPK because administration of AMPK inhibitor largely blocked this beneficial effect. This is a new explanation for the ER-protective effect of docosahexaenoic acid that developed after Begum et al 63 summarized that docosahexaenoic acid improves ER stress by blocking inositol trisphosphate receptor (InsP3R)-mediated ER Ca 2þ depletion. In addition, Okada et al 64 showed proteomic markers of improved ER function after n-3 polyunsaturated fatty-acid therapy in subjects with nonalcoholic steatohepatitis.
The ER participates in glucose homeostasis because of its involvement in insulin production in the pancreas. Elouil et al 65 reported that acute glucose stimulation, similar to physiological fed state, resulted in enhanced insulin synthesis and UPRs in cultured rat pancreatic islets. The UPRs were initiated as the adaptive mechanism to aid in maintaining and recovering the balance of capacity and demand. 49 Surpluses of glucose 66 and fatty acids 67 have also been reported to activate the PERK/eIF2a/ATF4/CHOP pathway and induce prolonged ER stress in pancreatic b cells, thereby reducing insulin expression and increasing b cell apoptosis. 68 Bachar et al 69 showed that glucose amplified palmitateinduced ER stress in cultured pancreatic b cells by increasing inositol-requiring protein (IRE) 1a levels and activating the c-Jun N-terminal kinases pathway, leading to increased b cell apoptosis. Ultimately, insulin secretion and circulating levels decrease. 70 
NUTRIENT SENSORS
Nutrient sensors allow cells to detect and adapt to elevated levels of nutrients and intracellular metabolites. 8 Such nutrient sensors include the cellular energy sensor, AMPK; the NAD þ -dependent protein deacetylases, sirtuins; and the nutrient/growth factor-sensitive kinase, mTOR. Combined, these sensors form a complex and sophisticated system that not only responds to nutrientrelated intracellular and extracellular stimuli but also regulates cross talk to achieve cellular homeostasis ( Figure 3 ). 71 Using cultured skeletal myotubes and 74 showed that SIRT1 regulates AMPK activity by modulating the acetylation status of its upstream activator liver kinase B1 (LKB1, also known as serine/threonine kinase 11 [STK11]) using cultured HEK293T cells. The activity of mTOR can be negatively affected by AMPK via phosphorylation of the upstream inhibitor, tuberous sclerosis complex (TSC), 75 or raptor, mTOR complex 1 (mTORC1) binding subunit. 76 Activated sirtuins, on the other hand, are able to directly regulate mTOR through TSC 77 or indirectly by blocking the TSC Figure 2 Unfolded protein response (UPR)-initiated inflammatory response. The UPR in mammalian cells is composed of 3 branches, which are initiated by 3 endoplasmic reticulum (ER) transmembrane sensor proteins-double-stranded RNA-dependent protein kinase-like ER kinase (PERK), inositol-requiring enzyme 1 (IRE1) , and activating transcription factor 6 (ATF6). 14 Activation of these sensors is dependent on the dissociation of the ER-resident chaperone glucose-regulated protein 78 (GRP78, also known as BiP) from their luminal domains. 51 Accumulation of improperly folded proteins at the ER results in the recruitment of BiP away from these UPR sensors, which are simultaneously activated. Activated UPR sensors then engage in a complex downstream signaling pathway, regulating gene expression related to the restoration of ER homeostasis through transcription factors. 49 Reproduced from Mandl et al 14 with permission. Abbreviations: ATF, activating transcription factor; BiP, glucose-regulated protein 78; C12, caspase-12; CHOP, C/EBP-homologous protein; eIF2a, eukaryotic initiation factor 2a; ER, endoplasmic reticulum; ERAD, ER-associated protein degradation; IRE1, inositol-requiring enzyme 1; JNK, c-Jun N-terminal kinase; Pc12, procaspase-12; PERK, protein kinase-like ER kinase; XBP1, X-box binding protein 1.
upstream inhibitor, protein kinase B/Akt. 78 Because these enzymes participate in the maintenance of cellular energy homeostasis, their dysfunction could lead to cellular energy deficiencies and thereby promote the transition of cells to aerobic glycolysis (Warburg effect).
Adenosine monophosphate-activated protein kinase
Adenosine monophosphate-activated protein kinase is a sensor of cellular energy status and a regulator of whole-body energy homeostasis. Adenosine monophosphate-activated protein kinase senses ATP, adenosine diphosphate (ADP), and AMP levels and thereby signals for restoration of ATP levels in energydepleted cells. 11 This protein kinase exists as a heterotrimeric complex composed of a catalytic a subunit and regulatory b and c subunits. Activation of AMPK is achieved by binding of AMP to its c subunit allosterically or phosphorylating Thr172 by its 2 upstream activators, LKB1 and Ca (2þ)/calmodulin-dependent protein kinase b.
11
Upon activation, AMPK, which functions as the fuel gauge for the cell, promotes catabolic pathways that replenish cellular ATP supplies, including increased glucose uptake via glucose transporter type 4, 79,80 glycolysis, [81] [82] [83] fatty-acid uptake via CD36, 84 fatty-acid oxidation by inhibition of acetyl-CoA carboxylase, 85 and mitochondrial biogenesis through activation of PGC1a. 43 Conversely, AMPK plays a role in inhibiting anabolic pathways, including synthesis of proteins, 86 fatty acids, 87 triacylglycerols, 88 and cholesterol. 89 Adenosine monophosphate-activated protein kinase inhibition under nutrient overload conditions. The natural response after feeding is a reduction in AMPK activity and a switch from catabolism to anabolism. Indeed, Assifi et al 90 and Wilson et al 91 reported that hepatic and muscle AMPK activity was elevated in a fasting rat model and significantly (P < 0.05) reduced after refeeding. Although AMPK activity resumes after nutrient levels return to basal level, multiple studies have provided evidence regarding the downregulation and inhibition of AMPK under excessive nutrient exposure in both animal (rat, mice) and cell (HepG2 cells) models, regardless of whether the diets consisted primarily of glucose, amino acid, or fat. [92] [93] [94] [95] Excessive glucose, amino acids, and lipids inhibit AMPK through different mechanisms. Excessive dietary fat can lead to AMPK inactivation by activating mTORC1. 93 It may also inhibit AMPK activity by dysregulating lipolysis and inhibiting fatty-acid oxidation. Gaidhu et al 96 showed that a mice model fed a high-fat diet presented with significantly (P < 0.05) increased adipose triglyceride lipase and phospholipase A2 content, as well as inhibited citrate synthase activity and expression of PGC-1a and palmitate oxidation. In addition, Wu et al 97 ascertained that the saturated fatty acid palmitate diminished AMPK activity by reducing AMPK Thr172 phosphorylation in both tissue 98 and cells 99 through increasing de novo ceramides synthesis and the activation of ceramide-dependent protein phosphatase 2A. Unsaturated fatty acids, on the other hand, did not initiate such detrimental effects. 97 Excessive glucose supply mainly affects AMPK activity via insulin. In response to glucose overload, insulin secretion is stimulated, which in turn suppresses AMPK activity through activation of Akt; this has been shown in an immortalized mouse embryonic fibroblasts model 100 and in incubated rat skeletal muscles. 101 Inhibition of AMPK activity by Akt is accomplished by decreasing the AMP/ATP ratio, 100 increasing AMPK phosphorylation at Ser 485/491 , 101 or activating mTOR.
102
Overload of amino acids or protein inhibits AMPK through the activation of mTOR. 103 Studies have demonstrated that excessive leucine and a high-protein diet enhanced mTOR phosphorylation and reduced AMPK activity in hepatocytes and rat livers, 104 C2C12 myoblast cells, 105 pancreatic b-cells, 106 and the hypothalamus. 107 Itani et al 108 and Kraegen et al 109 reported that decreased AMPK activity was accompanied by decreased acetyl-CoA carboxylase phosphorylation, resulting in increased malonyl-CoA and diacylglycerols content, which is responsible for insulin resistance in rat muscle Figure 3 Interaction among adenosine monophosphate-activated protein kinase (AMPK), silent mating type information regulator 2 homolog 1 (SIRT1), and mechanistic target of rapamycin (mTOR). The sensing and integration of intra-and extracellular signals, such as nutrient, oxygen, energy, growth, and stress, require the intricate cross talk of mTOR, AMPK, and SIRT. Abbreviations: Akt, protein kinase B; AMP, adenosine monophosphate; AMPK, AMP-activated protein kinase; ATP, adenosine triphosphate; LKB1, serine/threonine kinase 11; mTOR, mechanistic target of rapamycin; NAD, nicotinamide adenine dinucleotide; Nampt, nicotinamide phosphoribosyltransferase; SIRT1, silent mating type information regulator 2 homolog 1; TSC1, tuberous sclerosis complex 1; TSC2, tuberous sclerosis complex 2.
and liver. In addition, Joseph et al 110 proposed that protein phosphatase 2A affected the regulation of AMPK activity by dephosphorylating Thr172.
Silent mating type information regulator 2 homolog 1/ adenosine monophosphate-activated protein kinase cycle. Suchankova et al 111 presented results that AMPK activity decreased when SIRT1 was downregulated and vice versa. This synchronized relationship, referred to as the SIRT1/AMPK cycle by Ruderman et al, 112 occurs with excessive amino-acid and glucose stimulation, as reported by Coughlan et al. 95 Coughlan et al demonstrated that glucose or leucine simultaneously downregulated AMPK and SIRT1 when incubated with rat muscle. Surprisingly, Itani et al, 108 Lee et al, 102 and Suchankova et al 111 all reported that inhibition of AMPK is not directly correlated with changes in energy state (AMP/ATP ratio). Rather, decreased SIRT1 activity indicates that cellular redox (NAD þ /NADH) turbulence could be a potentially related factor. Considering that NAD þ /NADH redox balance affects AMPK activation, Rafaeloff-Phail et al 113 proposed that AMPK can be activated by mechanisms that do not involve changes in ATP levels. Specifically, AMPK is inhibited by NADH but activated by NAD þ . This hypothesis was supported in part by Lan et al, 74 who demonstrated with a cultured HEK293T cell model that SIRT1 increases the activity of LKB1, a major AMPK activator, by deacetylation, which in turn activates AMPK. Therefore, decreased ratios of NAD þ /NADH could lead to diminished SIRT1 and LKB1 activity, which may partially explain the decrease in AMPK activity. If this correlation between AMPK and the cellular redox state (NAD þ /NADH or lactate/ pyruvate ratio) via SIRT1 does exist, then AMPK may be a regulator of the Warburg effect by promoting oxidative metabolism rather than aerobic glycolysis.
Adenosine monophosphate-activated protein kinase as an anti-Warburg effect target. Woods et al 114 and Wilson et al 115 reported that the AMPK ortholog SNF1, which is the catalytic subunit of AMP-activated serine/ threonine protein kinase present in Saccharomyces cerevisiae, was required for respiration to switch from glycolysis (fermentation) to OXPHOS when glucose availability was low. Glycolytic genes were downregulated by SNF1 during the diauxic shift. 116 This ortholog also assisted with the transition to oxidative metabolism. 117 Similar to its yeast ortholog, mammalian AMPK is able to promote the energy-efficient OXPHOS at the expense of aerobic glycolysis (Warburg effect), which typically occurs rapidly in proliferating cells and proinflammatory immune cells. 118, 119 Because AMPK is considered an anti-Warburg target, drugs that act on AMPK, such as metformin, 120 salicylate, 121 and methotrexate, 122 have been developed to treat type 2 diabetes, inflammation, and cancer, respectively.
Sirtuins
Protein acetylation levels are controlled by 2 groups of enzymes that function oppositely, protein acetyltransferases and deacetylases. 123 Eighteen protein deacetylases have been identified and divided into 4 classes. The class III protein deacetylases are commonly referred to as sirtuins, 12 which are named after the silent mating type information regulator 2 (SIRT) from S. cerevisiae that also represents its mammalian orthologs. 124 To date, 7 mammalian sirtuins has been identified, SIRT1-7, each bearing an identical NAD þ -binding core and distinct N-and C-terminal extensions. 125 The latter detects differences in substrates, subcellular localization, and function, as is shown in Table 1 . 126 All sirtuins remove acyl groups from proteins, predominantly acetyl, as well as from succinyl, malonyl, and palmitoyl. 127 During the deacetylation reaction, NAD þ is consumed and cleaved, generating nicotinamide and ADP-ribose, which serves as an acyl acceptor to form an acyl-ADP-ribose product.
Regulation of sirtuin activity under nutrient overload. As stated previously, excessive nutrients lead to 2 types of stresses, lower NAD þ /NADH ratios 15, 16 and excessive generation of oxidants, 20 both of which can substantially affect the activity of sirtuins. As energy from various nutrients (in the form of electrons) is transferred via glycolysis and TCA pathways to NAD þ , which is then oxidized to NADH, the flow of cytosolic NADH generation is highly elevated and can be permanently increased in the case of persistent nutrient overload. 128 Sirtuin activity is thus negatively impacted due to the decreased NAD þ /NADH ratio because sirtuins consume NAD þ to regulate the deacetylation process while NADH inhibits its activity. 129 Meanwhile, the surrounding environment is in an oxidized state due to NADH overflow passing though mitochondrial OXPHOS complexes, which, in turn, leads to increased electron leakage and ROS production. This oxidative stress affects sirtuin in terms of its gene expression, posttranslational modification, and sirtuinprotein interaction, which is reviewed in detail by Santos et al. 126 In addition, the expression of sirtuin can be altered by nutrient overload directly. Using a mouse model, Noriega et al 130 demonstrated that SIRT1 transcription was positively controlled by the activation of the cyclic AMP response-element-binding protein (CREB) upon low nutrient availability, and negatively controlled by the activation of the carbohydrate response-element-binding protein (ChREBP). The binding sites of the 2 competing transcriptional factors, CREB and ChREBP, overlapped and shared the same sequence on the SIRT1 promoter site. During nutrient deprivation, protein kinase A activity was elevated via CREB, promoting SIRT1 transcription. Upon nutrient excess, ChREBP was imported into the nucleus, thereby repressing SIRT1 transcription. 130, 131 Apart from CREB Ample nutrients provide sufficient acyl groups (from acetyl-CoA) to sustain protein acetylation. As an outcome, pyruvate produced by glycolysis has 2 fates; it can be either converted to lactate or stored as a fatty acid. The former process usually occurs in anaerobic microorganisms or cancer cells. 144 In the latter case, pyruvate is converted to acetyl-CoA in the mitochondria of a normal mammalian cell, and then acetyl-CoA is transported out of mitochondria in the form of citrate for fatty-acid synthesis. As discussed by Guarente, 143 the acetyl group for protein acetylation in the cytosol is meant to be part of the energy storage; in other words, high acetylation in the cytosol under energy excess is a means for a cell to store energy. On the other hand, energy deprivation limits glycolysis 145 and activates sirtuin, 146 promoting deacetylation within the cytosol. 147 Oxidative phosphorylation is a rDNA transcription Abbreviations: AceCS2, acetyl-CoA synthetase 2; AMP, adenosine monophosphate; ATP, adenosine triphosphate; Bax, Bcl2 associated X protein; CPS1, carbamoyl phosphate synthetase 1; CtIP, C-terminal binding protein interacting protein; Foxo, forkhead box O; FXR, farnesoid X receptor; GDH, glutamate dehydrogenase; H3K9, histone 3 acetyl-lysine 9; H3K56, histone 3 acetyl-lysine 56; H4, histone 4; HIF, hypoxia-inducible factor; HMG-CoA synthase 2, 3-hydroxy-3-methylglutaryl CoA synthase 2; HSF1, heat shock factor 1; IDH2, isocitrate dehydrogenase 2; LCAD, long-chain acyl CoA dehydrogenase; LXR, liver X receptor; MnSOD, Mn-superoxide dismutase; NF-jB, nuclear factor-kappa B; OXPHOS, oxidative phosphorylation; p53, tumor suppressor protein 53; PER2, period circadian protein homolog 2; PGC-1a, peroxisome proliferator-activated receptor gamma coactivator 1a; SIRT1-7, silent mating type information regulator 2 homolog 1-7; SOD2, superoxide dismutase 2; SREBP, sterol regulatory element binding protein; STAT3, signal transducer and activator of transcription 3; TORC2/CRTC2, a transcriptional coactivator for the transcription factor CREB. a The activity and substrates of SIRT7 are still not clear.
facilitated because it can efficiently produce high levels of ATP per glucose input and catabolize glucose completely to carbon dioxide. Fatty-acid oxidation is also facilitated to provide acetyl-CoA for the TCA cycle under energy deprivation, which will not allow acetyl-CoA to relocate to the cytosol for storage or protein acetylation. 148 In addition, acetate produced from sirtuin deacetylation can be used as a substrate for acetyl-CoA synthesis to drive the TCA cycle and OXPHOS. Clearly, low energy assists in maintaining low acetylation due to high sirtuin activity and low acetyl-CoA availability. Protein acetylation/deacetylation and sirtuin activity function as a scale, representing the cell metabolic and energetic state and the relative balance between biosynthesis and catabolism. Energy surplus stimulates glycolysis, suppresses sirtuin activity, and promotes biosynthesis and storage. For cancer cells, glycolysis is driven by cell proliferation instead of biosynthesis, and thus energy is obtained by the Warburg mechanism. Sirtuin activity is severely reduced in cancer cells, especially mitochondrial SIRT3 and SIRT4 and nuclear SIRT6 (Figure 4) , [148] [149] [150] [151] [152] [153] to increase glutamine utilization. 148 
Mechanistic target of rapamycin
The mechanistic target of rapamycin is an evolutionarily conserved serine/threonine kinase that integrates both extracellular and intracellular stimuli, including growth factors, nutrients, energy status, and oxygen levels, to drive cell growth and proliferation 154, 155 ( Figure 5 ). 154, [156] [157] [158] [159] [160] [161] [162] [163] [164] This kinase exists in 2 distinct functional and structural complexes, mTORC1 and mTOR complex 2 (mTORC2). Of the 2 complexes, mTORC1 has been studied more extensively in terms of nutrient availability (especially amino acid), insulin and growth factor levels, and sensitivity to allosteric mTOR inhibitor rapamycin. 155 Unlike mTORC1, mTORC2 can be activated by growth factors but not nutrients, 165 and it cannot be acutely inhibited by rapamycin. 166 Under nutrient-rich conditions, mTORC1 regulates cellular metabolism, specifically promoting protein, lipid, and nucleotide synthesis and suppressing autophagy to achieve growth and proliferation. 154 Interplay between mechanistic target of rapamycin activation and mitochondrial oxidative function. An interesting interplay between mitochondrial metabolism Figure 4 Sirtuin quenching in the Warburg effect. The Warburg effect involves a considerably increased utilization of glutamine to compensate for the lack of a-ketoglutarate in the cell that resulted from a downregulated tricarboxylic acid (TCA) cycle. Silent mating type information regulator 2 homolog 3 (SIRT3) 149, 150 and silent mating type information regulator 2 homolog 6 (SIRT6) 151 function as corepressors of hypoxia-induced factor-1a, which upregulates glycolytic genes. SIRT6 also acts as a corepressor of cMYC, which promotes the expression of glutaminase 1 and, in turn, the conversion of glutamine to glutamate. 152 Silent mating type information regulator 2 homolog 4 (SIRT4) inhibits glutamate dehydrogenase, 153 which converts glutamate to a-ketoglutarate. Reproduced from Guarente 148 with permission. Abbreviations: a-KG, a-ketoglutarate; GDH, glutamate dehydrogenase; GLS1, glutaminase 1; HIF-1a, hypoxia-inducible factor 1a; TCA, tricarboxylic acid; SIRT3/4/6, silent mating type information regulator 2 homolog 3/4/6. and mTOR complex activity has been gradually unraveled in the past decade. More specifically, mitochondrial metabolism influences mTOR-raptor complex activity by altering the redox environment. 167 Sarbassov and Sabatini 167 determined that oxidizing agents successfully activated mTORC1 in a HEK293T cell model and that reducing agents effectively suppressed nutrient-induced mTORC1 activation, thereby indicating that a redoxsensitive mechanism plays a critical role in mTOR activation. This redox-dependent activation of the mTOR complex involves the interaction with raptor. 167, 168 It also requires TSC because oxidant or reducing agents fail to alter mTORC1 activity in TSC1 À/À or TSC2 À/À mouse embryonic fibroblasts model. 169 On the other hand, Schieke et al 168 showed that disruption of the mTOR-raptor complex by rapamycin lowered mitochondrial membrane potential, oxygen consumption, and ATP synthetic capacity in a HEK293T cell model. This research indicates that the mTOR complex regulates mitochondrial oxidative function, its membrane potential, oxygen consumption, and ATP synthetic capacity. As such, mTOR activity may be useful in determining the relative balance between glycolysis and aerobic sources of ATP generation. Indeed, Cunningham et al 46 used skeletal muscle tissues and cells to determine that mTOR controls mitochondrial oxidative function through a YY1-PGC-1a transcriptional complex. Ji et al 47 provided support for the results of Cunningham et al 46 by showing that activation of the mTOR-YY1-PGC-1a pathway significantly increased intracellular ATP synthesis (P < 0.05), oxygen consumption rate (P < 0.01), activity of citrate synthase (P < 0.01), and mitochondrial DNA copy number (P < 0.01)in C2C12 myoblasts.
Contribution of mechanistic target of rapamycin activation to endoplasmic reticulum stress. Hyperactivation of the mTOR pathway activates ER Figure 5 Mechanistic target of rapamycin (mTOR) signaling pathway. Upstream signaling regulates mTOR complex 1 (mTORC1) primarily through the regulation of Ras homolog enriched in brain (Rheb), a small GTPase that, when bound to guanosine triphosphate (GTP), directly interacts with and activates mTORC1. 156 Growth factor activates mTORC1 through the tuberous sclerosis complex (TSC)/Rheb axis 157 ; glucose, oxygen, and energy status impact mTORC1 via adenosine monophosphate-activated protein kinase (AMPK)-dependent pathways 154 ; and amino acids activate mTORC1 by promoting the GTP charging of lysosomal surface resident Rag A/B. 158 When activated, mTORC1 promotes protein synthesis by inducing ribosome biogenesis 159 and mRNA translation, 160 specifically through phosphorylating p70 S6 kinase and eIF 4E binding protein 1 (4E-BP1) 161 ; lipid synthesis by activating SREBP-1 transcription factor 162 ; and nucleotide synthesis through phosphorylating S6 kinase. 163 Activated mTORC1 also actively suppresses autophagy by phosphorylating autophagy/beclin-1 regulator 1 (AMBRA1).
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Abbreviations: Akt, protein kinase B; AMP, adenosine monophosphate; AMPK, adenosine monophosphate-activated protein kinase; ATP, adenosine triphosphate; ERK, extracellular signal-regulated kinases, also known as mitogen-activated protein kinase; GDP, guanosine diphosphate; GTP, guanosine triphosphate; LKB1, serine/threonine kinase 11; MEK, mitogen-activated ERK kinase; mTORC1/2, mechanistic target of rapamycin 1/2; PI3K, phosphoinositide 3-kinase; REDD1, regulated in development and DNA damage responses 1; Rheb, Ras homolog enriched in brain; TSC1/2, tuberous sclerosis complex 1/2.
stress and triggers UPRs, presumably through increased protein synthesis, which overwhelms the capacity of the ER to fold proteins. 170, 171 Although mTOR and UPRs have traditionally been considered as separate pathways, the identification of mTOR-UPR interaction, reviewed by Appenzeller-Herzog and Hall, 171 has opened a relatively new area of research. When conditions are favorable to growth, insulin, as a growth factor, signals via phosphoinositide 3 kinase to Akt, which phosphorylates and inactivates TSC2, an upstream inhibitor of mTORC1, on multiple serine/threonine residues. 172, 173 Loss of TSC leads to constitutive activation of mTORC1, 170 which stimulates the c-Jun N-terminal kinase pathway. Activated c-Jun N-terminal kinases can phosphorylate and degrade insulin receptor substrate 1 on serine residues, eventually leading to insulin resistance. 174 This is the best documented ER stress pathway downstream of mTOR, and it occurs in parallel to other mechanism such as mTORC1 and ER stress-facilitated de novo lipogenesis, 175 which is strongly driven by insulin through the activation of transcription factor SREBP-1c. 53 Another way for overnutrition-induced mTOR hyperactivation to cause insulin resistance is through the activation of S6 kinase, which also leads to the serine phosphorylation of insulin receptor substrate 1. 176 Excessive leucine and glucose have been shown to cause insulin resistance by activating mTOR/p70 S6 kinase, which leads to the phosphorylation of serine residues (S 307 , S
635
) on insulin receptor substrate 1, 92, 177 thereby impairing insulin signaling. The detrimental effects of mTOR-UPR interaction on insulin signaling and lipogenesis can be mitigated by the administration of rapamycin, which allosterically inhibited mTOR activation, or by deliberately activating AMPK. 92, 93 For instance, Li et al 93 showed that inhibition of mTORC1 signaling by rapamycin attenuated ER stress and lipid accumulation induced by high glucose and palmitate in HepG2 cells.
Participation of mechanistic target of rapamycin in central carbon metabolism. Several studies have shown a critical link between mTOR activation and energy homeostasis. Wagle et al 178 showed that insulin regulation of glucose-6-phosphate dehydrogenase gene expression was rapamycin-sensitive, implicating mTOR involvement in the regulation of glycolysis. Glucose-6-phosphate dehydrogenase controls the carbon flow through the pentose phosphate pathway, which provides the reducing agent NADPH needed for biosynthesis regulated by mTOR. 178 These results are supported by Düvel et al, 162 who demonstrated that mTORC1 induced the expression of enzymes involved in glucose uptake and glycolysis (including glucose-6-phosphate dehydrogenase) via the transcription factor hypoxiainducible factor 1a (HIF-1a) and enzymes involved in the pentose phosphate pathway (including 6-phosphogluconate dehydrogenase), as well as de novo lipid/sterol synthesis through sterol regulatory element binding proteins. 162 A study completed by Hudson et al 179 showed mTOR activation resulted in the accumulation of HIF-1a as well as HIF-1a-dependent regulation of glycolytic gene expression in a PC-3 human prostate cancer cell line. These results indicate that mTOR acts as an upstream activator of HIF-1a. Recent research conducted by Chen et al 180 further determined that mTORC1 acts through an importer protein, Karyopherin subunit alpha-2, to upregulate glycolysis in a mouse embryonic fibroblasts model.
It must be noted that cross talk exists between glycolysis and mTOR regulation. Lee et al 181 hypothesized that GAPDH regulates mTORC1 activity in response to glucose availability based on the following data. Under low glucose conditions, GAPDH bound to the Ras homolog enriched in brain (Rheb) protein and, in turn, inhibited mTORC1 activation. 181 High glycolytic flux, however, suppressed the interaction between GAPDH and Rheb and allowed Rheb to activate mTORC1. 181 Lee et al. reported that the glycolytic intermediate glyceraldehyde-3-phosphate can assist the activation of mTORC1 by destabilizing the binding of Rheb-GAPDH. 181 Studies conducted by Buller et al 182 supported the findings of Lee et al 181 as mesangial cells exposed to excessive glucose presented with enhanced glucose transporter type 1 expression, which activated mTOR by increasing mTOR-Rheb binding and decreasing GAPDH-Rheb binding.
Mechanistic target of rapamycin as a positive indicator of the Warburg effect. Aberrant activation of mTOR complexes is considered a biomarker in an array of metabolic diseases, including cancer, obesity, and autoimmune disorders. 157 Nutrient-induced mTOR activation upregulates glycolytic flux mainly though HIF1a-mediated transcription regulation. An increase in the rate of glycolysis, even in the presence of oxygen, can occur as a means to maintain cell survival due to hyperactive mTOR signaling. Sun et al 183 showed that mTOR signaled the expression of pyruvate kinase M2, a rate-limiting glycolytic enzyme in the oncogenic Warburg effect, and the expression of pyruvate kinase M2 through HIF-1a and c-Myc-heterogeneous nuclear ribonucleoproteins cascades in a mouse embryonic fibroblasts cell model. Interestingly, pyruvate kinase M2 sustained mTORC1 activity by promoting de novo serine synthesis 184 or by phosphorylating the mTORC1 inhibitor, Akt1 substrate 1. 185 Clearly, the status of mTOR can be considered a major positive indicator of the Warburg effect.
CONCLUSION
Chronic nutrient overload disturbs metabolic homeostasis, rewires bioenergetic pathways, and alters cellular energetic state. The overflux of intracellular metabolites burdens the organelles within the cell, fuels the pathways favoring energy storage and biosynthesis, and inhibits energy-consuming pathways. Glycolysis is elevated to accelerate nutrient oxidation, but the process is not equipped to degrade nutrient completely, leaving elevated amounts of half-oxidized intermediate in the cell, rendering the cell predisposed to biosynthesis. The degree of protein acetylation is elevated, reducing sirtuin activity while activating the mTOR complex to answer biosynthetic signals. Mitochondria is fully saturated, with both the TCA cycle and electron transport chain working continuously, a sustained high energy level suppresses AMPK activity, and eventually oxidative phosphorylation complexes are damaged with decreased bioenergetic efficiency. Proton leakage and oxidative stress escape mitochondria and spread to the rest of the cell, doubling the suppression of sirtuin activity and activating inflammatory signaling. Under the influence of mTOR activation, the ER strains due to increased workload of protein packaging and de novo lipogenesis. Sustained ER stress can cause insulin resistance indirectly by lipogenesis or directly by interfering with insulin signaling through the activation of proinflammatory pathways. The UPRs are then activated in an attempt to ameliorate ER stress; failure to do so leads to cell apoptosis. Under prolonged nutrient overload, these changes in key organelles and nutrient sensors are likely to remain, thereby laying the foundation for the development of a metabolic disorder.
Small molecules that act upon key enzymes and nutrient sensors, such as metformin, salicylate, and methotrexate, have been studied as a potential cure for different metabolic disorders. To date, they have yet to show efficacy in the clinic. Resveratrol is another compound that has demonstrated impacts on metabolic homeostasis in lab settings; resveratrol decreased PGC-1a acetylation and increased PGC-1a activity through activation of SIRT1 in a mice model, 186 which explains the association of resveratrol consumption with an induction of genes for oxidative phosphorylation and mitochondrial biogenesis. 186 However, research has also contradicted these findings and concluded that feeding rodents resveratrol has no effect on mitochondrial biogenesis. 187 Nonetheless, the increasing use of a high-throughput screening process offers the exciting possibility of new discoveries by providing efficient measurements of the effects of agents such as novel small molecules ZLN005 188 and SR-18292. 189 
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